CIC
NAGE

Chase Investment Counsel’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History

Chase Investment Counsel’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$349K Buy
+24,246
New +$349K 0.11% 112